Shares of WELL Health Technologies Corp. (TSE:WELL – Get Free Report) have received an average recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price objective among brokers that have covered the stock in the last year is C$7.13.
Separately, Stifel Nicolaus lowered their target price on shares of WELL Health Technologies from C$11.00 to C$10.00 in a report on Monday, April 29th.
View Our Latest Stock Analysis on WELL Health Technologies
WELL Health Technologies Trading Up 0.2 %
WELL Health Technologies Company Profile
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
Featured Articles
- Five stocks we like better than WELL Health Technologies
- How to invest in blue chip stocks
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- What is Put Option Volume?
- Progress Software Stock Back in the Green After Beating Forecasts
- Trading Halts Explained
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.